INT132355

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.09
First Reported 2006
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.85
Pain Relevance 0.31

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

molecular_function (Epx) cellular_component (Epx) biological_process (Epx)
Anatomy Link Frequency
eosinophil 1
Epx (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Analgesic 1 97.56 Very High Very High Very High
Inflammation 11 96.44 Very High Very High Very High
spastic colon 4 50.00 Quite Low
Inflammatory marker 2 50.00 Quite Low
abdominal pain 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
INFLAMMATION 10 96.44 Very High Very High Very High
Hypersensitivity 4 91.84 High High
Anaphylaxis 2 80.40 Quite High
Arthus Reaction 1 56.48 Quite High
Hemolysis 1 51.76 Quite High
Collagenous Colitis 4 50.00 Quite Low
Functional Bowel Disorder 2 50.00 Quite Low
Contact Dermatitis 1 31.92 Quite Low
Irritable Bowel Syndrome /

Irritable Bowel Syndrome Super

2 5.00 Very Low Very Low Very Low
Abdominal Pain 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In addition, arctigenin inhibited eosinophil peroxidase and activated myeloperoxidase in inflamed tissues.
Positive_regulation (activated) of eosinophil peroxidase in eosinophil
1) Confidence 0.09 Published 2010 Journal Arch. Pharm. Res. Section Abstract Doc Link 20607501 Disease Relevance 0.85 Pain Relevance 0.31
RESULTS: EPX levels were enhanced in faeces from CC patients (median 3.8 microg/g (0.47-16.2)) compared to patients with IBS (0.44 microg/g (0.25-1.8)), p<0.001, and HC (0.46 microg/g (0.21-1.3)), p<0.001.
Positive_regulation (enhanced) of EPX
2) Confidence 0.05 Published 2006 Journal Scand. J. Gastroenterol. Section Body Doc Link 16373277 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox